Brent Stockwell

Dr. Brent Stockwell is a Professor of Biological Sciences and Chemistry at Columbia University, a prolific inventor, and a serial entrepreneur. His lab studies cell death and metabolism in order to better understand and treat cancer and neurodegeneration. ProJenX, a startup based on novel kinase inhibitors for treatment of ALS co-developed by Dr. Brent Stockwell and Dr. Hynek Wichterle, raised a $5.1M seed financing led by Medical Excellence Capital, which created ProJenX in collaboration with Project ALS, a leading nonprofit organization committed to ALS research.